Treatment with teriflunomide resulted in a 63% risk reduction relative to placebo in preventing the first symptoms of multiple sclerosis in individuals with radiologically isolated syndrome.
/PRNewswire/ - Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, today announced.
An MS diagnosis is tough to accept, but the treatment landscape is changing montrealgazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from montrealgazette.com Daily Mail and Mail on Sunday newspapers.